Notably, several BARD1 isoforms lacking exon 3, such as BARD1β (lacking exons 2 and 3) and BARD1δ (lacking exons 2–6), antagonize full-length BARD1 and confer cancer susceptibility and oncogenicity15,17. The gene discussed is BARD1; the disease is cancer.